Cargando…
The Evolving Landscape of Antibody–Drug Conjugates: In Depth Analysis of Recent Research Progress
[Image: see text] Antibody–drug conjugates (ADCs) are targeted immunoconjugate constructs that integrate the potency of cytotoxic drugs with the selectivity of monoclonal antibodies, minimizing damage to healthy cells and reducing systemic toxicity. Their design allows for higher doses of the cytoto...
Autores principales: | Sasso, Janet M., Tenchov, Rumiana, Bird, Robert, Iyer, Kavita A., Ralhan, Krittika, Rodriguez, Yacidzohara, Zhou, Qiongqiong Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655051/ https://www.ncbi.nlm.nih.gov/pubmed/37821099 http://dx.doi.org/10.1021/acs.bioconjchem.3c00374 |
Ejemplares similares
-
PEGylated
Lipid Nanoparticle Formulations: Immunological
Safety and Efficiency Perspective
por: Tenchov, Rumiana, et al.
Publicado: (2023) -
Gut Microbiome–Brain
Alliance: A Landscape
View into Mental and Gastrointestinal Health and Disorders
por: Sasso, Janet M., et al.
Publicado: (2023) -
Exosomes—Nature’s
Lipid Nanoparticles,
a Rising Star in Drug Delivery and Diagnostics
por: Tenchov, Rumiana, et al.
Publicado: (2022) -
Molecular Glues:
The Adhesive Connecting Targeted
Protein Degradation to the Clinic
por: Sasso, Janet M., et al.
Publicado: (2022) -
The Progress and
Promise of RNA Medicine—An
Arsenal of Targeted Treatments
por: Sasso, Janet M., et al.
Publicado: (2022)